New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

LEQEMBI (lecanemab-irmb) injection

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email query@southdelhipharma.com to discuss.

LEQEMBI is an amyloid beta-directed antibody indicated for the treatment of Alzheimer’s disease. Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials.

Drug Name: LEQEMBI
Active Ingredient: LECANEMAB-IRMB
Company: EISAI INC
Approval Date: 06-Jan-2023
FDA-approved use on approval date: Treatment of Alzheimer’s disease
Dosage Forms And Strengths: Injection:
• 500 mg/5 mL (100 mg/mL) solution in a single-dose vial
• 200 mg/2 mL (100 mg/mL) solution in a single-dose vial

Do you need this medicine in India?

To help you get this medicine – LEQEMBI (lecanemab-irmb)), a prescription from the Registered Medical Practitioner (RMP) is required. Contact Mr. Tarun at 9891296838 via Call or WhatsApp for availability in India.

Category
LEQEMBI (lecanemab) cost Price Delhi India
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

Description

Lecanemab is indicated for the treatment of Alzheimer’s disease in people who have mild cognitive impairment or mild dementia, but not in people who already have moderate or severe dementia.

LEQEMBI (lecanemab-irmb) injection, for intravenous use Initial U.S. Approval: 2023

See full prescribing information : Click Here

Need Help Getting Medicine? Here’s How We Can Assist You.

Brand Name “LEQEMBI” or Generic Name “lecanemab-irmb” can be imported for personal use under “Named Patient Program” treatment in Delhi, Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Jaipur, Aurangabad, Pune, Bangalore, Hyderabad, Chennai, Visakhapatnam, Coimbatore, Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu, Telangana, India. Contact us at support@southdelhipharma.net, southdelhipharma@gmail.com or  you can call at 9891296838 or WhatsApp at 9891296838

Related Products

Related products